|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,284.00 GBX | +0.64% |
|
-2.55% | -3.67% |
| 11:38am | The Warsh test |  |
| 10:31am | Big pharma taps UK playbook to pressure European capitals on drug prices | RE |
| Market Cap | 28TCr 24TCr 22TCr 21TCr 39TCr 26,14400Cr 39TCr 2,59300Cr 1,01000Cr 12,80300Cr 1,03800Cr 1,01600Cr 44,36800Cr | P/E Ratio 2026 * |
22.3x | P/E Ratio 2027 * | 19.5x |
|---|---|---|---|---|---|
| Enterprise Value | 30TCr 25TCr 23TCr 22TCr 41TCr 27,96300Cr 42TCr 2,77300Cr 1,08000Cr 13,69400Cr 1,11000Cr 1,08600Cr 47,45600Cr | EV / Sales 2026 * |
4.67x | EV / Sales 2027 * | 4.3x |
| Free-Float |
96.63% | Yield 2026 * |
1.87% | Yield 2027 * | 1.98% |
Last Transcript: AstraZeneca PLC
| 1 day | +0.64% | ||
| 1 week | -2.55% | ||
| Current month | -3.75% | ||
| 1 month | -2.55% | ||
| 3 months | -7.52% | ||
| 6 months | -1.64% | ||
| Current year | -3.67% |
| 1 week | 11,484 |  | 13,784 |
| 1 month | 11,232 | | 14,120 |
| Current year | 11,232 | | 15,732 |
| 1 year | 10,103 | | 15,732 |
| 3 years | 9,461 | | 15,732 |
| 5 years | 8,029 | | 15,732 |
| 10 years | 3,680 | | 15,732 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 01/10/2012 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 01/08/2021 |
Pam Cheng
COO | Chief Operating Officer | 55 | 01/06/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 06/04/1999 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 01/10/2012 |
Philip Broadley
BRD | Director/Board Member | 65 | 27/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/05 | Sell | See Remarks | -11,893 | 0.0008% | ||
| 14/05 | Fiscal year | Chief Executive Officer | 18,359 | 0.0012% | ||
| 06/05 | Free | See Remarks | 1 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.64% | -2.55% | +22.80% | +12.69% | 28TCr | |
| -0.61% | -1.94% | +39.00% | +150.72% | 1,00100Cr | |
| -0.20% | -0.77% | +51.51% | +43.20% | 57TCr | |
| +0.40% | -1.31% | +16.56% | +60.47% | 39TCr | |
| -1.18% | +2.29% | +24.04% | +16.53% | 33TCr | |
| -0.43% | +1.12% | +24.21% | +31.89% | 28TCr | |
| -1.86% | +4.01% | -43.73% | -49.21% | 19TCr | |
| -0.77% | +0.95% | +17.69% | +51.46% | 19TCr | |
| +2.36% | +1.38% | +14.80% | +61.34% | 16TCr | |
| +0.15% | +1.32% | +6.72% | -35.00% | 15TCr | |
| Average | -0.16% | +0.68% | +17.36% | +34.41% | 35.25TCr | |
| Weighted average by Cap. | -0.29% | -0.18% | +26.59% | +62.82% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.33TCr 5.46TCr 5.03TCr 4.72TCr 8.86TCr 5,98700Cr 8.95TCr 59TCr 23TCr 2,93200Cr 24TCr 23TCr 10,16000Cr | 6.72TCr 5.79TCr 5.33TCr 5TCr 9.39TCr 6,34900Cr 9.49TCr 63TCr 25TCr 3,10900Cr 25TCr 25TCr 10,77500Cr |
| Net income | 1.25TCr 1.08TCr 991.05Cr 930.5Cr 1.75TCr 1,18100Cr 1.77TCr 12TCr 4.56TCr 58TCr 4.69TCr 4.59TCr 2,00400Cr | 1.41TCr 1.22TCr 1.12TCr 1.05TCr 1.98TCr 1,33700Cr 2TCr 13TCr 5.16TCr 65TCr 5.31TCr 5.19TCr 2,26800Cr |
| Net Debt | 1.92TCr 1.66TCr 1.53TCr 1.43TCr 2.69TCr 1,82000Cr 2.72TCr 18TCr 7.03TCr 89TCr 7.22TCr 7.07TCr 3,08800Cr | 1.2TCr 1.03TCr 952.72Cr 894.52Cr 1.68TCr 1,13500Cr 1.7TCr 11TCr 4.39TCr 56TCr 4.51TCr 4.41TCr 1,92600Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/26/16 | 13,284.00 p | +0.64% | 42,60,905 |
| 15/26/15 | 13,200.00 p | -1.95% | 18,18,098 |
| 12/26/12 | 13,462.00 p | -0.85% | 20,94,732 |
| 11/26/11 | 13,578.00 p | +0.85% | 22,31,675 |
| 10/26/10 | 13,464.00 p | -1.23% | 17,62,153 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
Select your edition
All financial news and data tailored to specific country editions
